To include your compound in the COVID-19 Resource Center, submit it here.

Massachusetts House dilutes Medicaid drug pricing bill

The Massachusetts House of Representatives Wednesday took some of the sting out of Medicaid drug price regulation provisions that will be incorporated into a budget bill, passing an amendment that scraps requirements for drug manufacturers to publicly justify prices and eliminates a mandate for a state commission to publish proposed values

Read the full 510 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE